Financhill
Sell
18

PHAT Quote, Financials, Valuation and Earnings

Last price:
$5.12
Seasonality move :
23.83%
Day range:
$4.76 - $5.91
52-week range:
$4.07 - $19.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.85x
P/B ratio:
--
Volume:
3.3M
Avg. volume:
1.3M
1-year change:
-51.7%
Market cap:
$356.5M
Revenue:
$55.3M
EPS (TTM):
-$5.35

Earnings Data

Next earnings date for PHAT
May 09
2025
Most recent earnings per share
-$1.05
Beat by $0.03
(Mar 6/2025)
Consensus Estimate
-$1.08
(Mar 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

PHAT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $37.2M -- -- -$1.01 --
05/09/2025 Q1 $27.9M -- -- -$1.06 --
03/06/2025 Q4 $25.7M $29.7M -$1.05 -$1.08 $0.03
11/07/2024 Q3 $12.4M $16.4M -$1.32 -$1.47 $0.15
08/08/2024 Q2 $5.7M $7.3M -$1.56 -$1.24 -$0.32
05/09/2024 Q1 $2.1M $1.9M -$1.42 -$1.22 -$0.20
03/07/2024 Q4 $379.2K $682K -$1.45 -$1.00 -$0.45
11/09/2023 Q3 -- -- -$0.76 -$0.97 $0.21
08/10/2023 Q2 -- -- -$0.84 -$0.95 $0.11
05/10/2023 Q1 -- -- -$0.89 -$1.29 $0.40
02/28/2023 Q4 -- -- -$1.33 -$1.37 $0.04
11/08/2022 Q3 -- -- -$1.32 -$1.33 $0.01
08/02/2022 Q2 -- -- -$1.33 -$1.12 -$0.22
05/10/2022 Q1 -- -- -$1.07 -$1.02 -$0.05
03/01/2022 Q4 -- -- -$0.95 -$1.12 $0.17
11/08/2021 Q3 -- -- -$0.98 -$1.03 $0.05
08/10/2021 Q2 -- -- -$1.00 -$0.99 -$0.01
05/11/2021 Q1 -- -- -$0.96 -$1.32 $0.36
03/30/2021 Q4 -- -- -$1.58 -$1.12 -$0.46
11/10/2020 Q3 -- -- -$1.02 -- --
08/06/2020 Q2 -- -- -$0.64 -- --
05/12/2020 Q1 -- -- -$0.62 -- --
03/19/2020 Q4 -- -- -$3.96 -- --
11/25/2019 Q3 -- -- -$2.98 -- --

Phathom Pharmaceuticals Earnings Questions

  • How Much did Phathom Pharmaceuticals Generate in Revenue Last Quarter?

    Phathom Pharmaceuticals reported $29.7M worth of top line sales in its most recent quarter.

  • Did Phathom Pharmaceuticals Beat Earnings Last Quarter?

    Phathom Pharmaceuticals announced earnings per share of -$1.05 which represents a beat of analyst forecast a -$1.08 per share.

  • Is Phathom Pharmaceuticals Profitable?

    Phathom Pharmaceuticals reported $25.8M that represents $0.36 per share over the last quarter.

  • What is the Analyst Consensus for Phathom Pharmaceuticals EPS Next Year?

    Phathom Pharmaceuticals's earnings are forecast to decrease from -$5.29 per share to -$4.70 per share next year representing a decrease of -26.34%.

  • When is Phathom Pharmaceuticals's Earnings Date?

    Phathom Pharmaceuticals's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

3 Smartest Dividend Stocks to Buy Now
3 Smartest Dividend Stocks to Buy Now

When the market entered a correction in February and March,…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
42
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
100
DLICY alert for Apr 2

Dai-ichi Life Holdings [DLICY] is up 100.91% over the past day.

Buy
78
GATE alert for Apr 2

Marblegate Acquisition [GATE] is up 86.64% over the past day.

Sell
15
PCVX alert for Apr 2

Vaxcyte [PCVX] is down 14.62% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock